Zhang, H., Maitta, R.W., Bhattacharyya, P.K., Florea, A.D., Sen, F., Wang, Q. and Ratech, H. (2011) γ-Synuclein Is a Promising New Marker for Staining Reactive Follicular Dendritic Cells, Follicular Dendritic Cell Sarcoma, Kaposi Sarcoma, and Benign and Malignant Vascular Tumors. The American Journal of Surgical Pathology, 35, 1857-1865.
https://doi.org/10.1097/PAS.0b013e3182297c2e

has been cited by the following article:

• TITLE: Follicular Dendritic Cell Sarcoma: A Rare Case Study of Meta-Synchronous Double Primary Cancers Follicular Dendritic Sarcoma and Invasive Breast Cancer

  AUTHORS: Emad Mohsen Barsoum, Sara El Sherif, May Gamal Ashour, Mohsen Samy Barsoum

  KEYWORDS: Follicular Dendritic Sarcoma, FDCS, STS, Breast Cancer

  JOURNAL NAME: Journal of Cancer Therapy, Vol.13 No.6, June 23, 2022

  ABSTRACT: Follicular dendritic cell sarcomas (FDC-Sarcoma) are a rare type of tumor. Although most cases (60%) originate in the cervical, abdominal, or axillary lymph nodes, extranodal origin from secondary lymphatic tissue such as the tonsils, Waldeyer’s ring, or MALT is also prevalent (40%). We report a case of cervical FDCS in a 51-year-old female who developed invasive breast cancer during follow-up. We review the presentation and management of this disorder, emphasizing the differential diagnosis. The patient was continuously monitored and has been free of recurrences for ten years. For FDC Sarcoma of the head and neck, this case suggests surgical resection combined with chemotherapy and radiotherapy as a therapeutic option.